MENU
+Compare
SPHRF
Stock ticker: OTC
AS OF
Nov 4 closing price
Price
$0.21
Change
+$0.05 (+31.25%)
Capitalization
113.44M

SPHRF Starpharma Holdings Ltd. Forecast, Technical & Fundamental Analysis

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications... Show more

SPHRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SPHRF with price predictions
Nov 12, 2025

Momentum Indicator for SPHRF turns positive, indicating new upward trend

SPHRF saw its Momentum Indicator move above the 0 level on November 03, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 51 similar instances where the indicator turned positive. In of the 51 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SPHRF just turned positive on November 06, 2025. Looking at past instances where SPHRF's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

SPHRF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPHRF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.168) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (27.624) is also within normal values, averaging (322.723).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPHRF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SPHRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4-6 Southampton Crescent
Phone
+61 385322700
Employees
32
Web
https://www.starpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCRRF54.950.47
+0.86%
Recruit Holdings Co., Ltd.
MONOF15.31N/A
N/A
Monotaro Co., Ltd.
SLOIF41.20N/A
N/A
Soitec, Bernin
ZDGGF0.12N/A
N/A
Zoo Digital Group Plc
GLNLF0.10N/A
N/A
GALAN LITHIUM LTD.

SPHRF and Stocks

Correlation & Price change

A.I.dvisor tells us that SPHRF and CGEN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRF
1D Price
Change %
SPHRF100%
N/A
CGEN - SPHRF
26%
Poorly correlated
-2.33%
SPHRY - SPHRF
25%
Poorly correlated
+21.49%
NURPF - SPHRF
23%
Poorly correlated
N/A
SOLTF - SPHRF
23%
Poorly correlated
N/A
ASPHF - SPHRF
22%
Poorly correlated
N/A
More